TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ANTX

AN2 Therapeutics Inc

Healthcare · Biotechnology

5.00$ -1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANTX
Line item 2019 2020 2021 2022 2023 2024 2025
-25.7% +1,442.7% +57.0% +35.3% -33.6% -32.7%
-25.7% +1,319.6% +64.1% +12.1% -21.9% -30.5%
-27.3% +197.2% +125.0% -42.5% +36.5% -6.6%
-27.3% +1,338.7% +64.0% +11.7% -22.1% -30.6%
-78.6% +200.0%
+67.2% +129.8% +110.9% +95.4% -27.1% -13.2%
+817.6% +132.7% +111.7% +95.4% -27.1% -14.8%
+158.8% +705.3% +99.6% +26.1% +24.0% -8.9%
-42.8% +2,150.4% +54.1% +30.8% -34.4% -35.2%
+0.0% +0.0% -18.1% +53.8% +26.4% +1.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?